CS logo
small CS logo
Banner MD Anderson Cancer Center

Gilbert, Arizona, United States
Cancer treatment center in Gilbert, Arizona
2946 E Banner Gateway Dr, Gilbert, AZ 85234

About Banner MD Anderson Cancer Center


"Banner MD Anderson patients experience customized, comprehensive and compassionate cancer care. Patients have a team of experts who understand the nuances of each type of cancer to develop a treatment plan based on his or her unique needs. Our cancer experts include medical oncologists, surgeons, radiation oncologists, physician specialists, nurses and clinical support staff. Clinical nurse navigators work closely with patients, guiding them through their first visit and serving as a single point of contact throughout their care. Learn more about the unprecedented cancer care that is provided at Banner MD Anderson."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Banner MD Anderson Cancer Center


During the past decade, Banner MD Anderson Cancer Center conducted 145 clinical trials. In the 10-year time frame, 145 clinical trials started and 47 clinical trials were completed, i.e. on average, 32.4% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 36 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years8817172424191935352424111155221100223355101012129955Started TrialsCompleted Trails201520162017201820192020202120222023010203040
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer
2011-04-01
2013-01-01
Unknown status
140
Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer
2011-02-08
2021-11-30
Active, not recruiting
301
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
2011-05-25
Active, not recruiting
1,673
Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial Carcinoma
2011-02-01
2015-07-01
Terminated
22
S0820, Adenoma and Second Primary Prevention Trial
2013-03-01
2032-02-01
Recruiting
1,340
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
2011-10-01
2041-10-01
Recruiting
99,999
Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
2011-12-01
2015-02-01
Terminated
266
Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
2012-03-09
2019-08-15
Completed
32

Rows per page:

1–100 of 179

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Banner MD Anderson Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "Kite, A Gilead Company" with 9 trials sponsored, "M.D. Anderson Cancer Center" with 9 trials sponsored, "Eli Lilly and Company" with 6 trials sponsored and "SWOG Cancer Research Network" with 6 trials sponsored. Other sponsors include 131 different institutions and companies that sponsored additional 100 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Banner MD Anderson Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Merck Sharp & Dohme LLC" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 53 different institutions and companies that were collaborators in the rest 57 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 14National CancerInstitute (NCI): 14Kite, A Gilead Company: 9Kite, A Gilead Company: 9M.D. Anderson Cancer Center: 9M.D. Anderson Cancer Center: 9Eli Lilly and Company: 6Eli Lilly and Company: 6SWOG Cancer ResearchNetwork: 5SWOG Cancer ResearchNetwork: 5Seagen Inc.: 5Seagen Inc.: 5Galera Therapeutics, Inc.: 4Galera Therapeutics, Inc.: 4Merck Sharp & Dohme LLC: 4Merck Sharp & Dohme LLC: 4Novartis Pharmaceuticals: 4Novartis Pharmaceuticals: 4Taiho Oncology, Inc.: 4Taiho Oncology, Inc.: 4

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 20National CancerInstitute (NCI): 20NRG Oncology: 8NRG Oncology: 8Merck Sharp & Dohme LLC: 5Merck Sharp & Dohme LLC: 5Bristol-Myers Squibb: 4Bristol-Myers Squibb: 4AstraZeneca: 2AstraZeneca: 2Bayer: 2Bayer: 2Canadian Cancer Trials Group: 2Canadian Cancer Trials Group: 2Celgene Corporation: 2Celgene Corporation: 2Daiichi Sankyo Co., Ltd.: 2Daiichi Sankyo Co., Ltd.: 2Merck KGaA,Darmstadt, Germany: 2Merck KGaA,Darmstadt, Germany: 2

Clinical Trials Conditions at Banner MD Anderson Cancer Center


According to Clinical.Site data, the most researched conditions in "Banner MD Anderson Cancer Center" are "Breast Cancer" (8 trials), "Metastatic Breast Cancer" (7 trials), "Pancreatic Cancer" (7 trials), "Carcinoma, Non-Small-Cell Lung" (5 trials) and "Lymphoma" (5 trials). Many other conditions were trialed in "Banner MD Anderson Cancer Center" in a lesser frequency.

Clinical Trials Intervention Types at Banner MD Anderson Cancer Center


Most popular intervention types in "Banner MD Anderson Cancer Center" are "Drug" (141 trials), "Biological" (46 trials), "Other" (25 trials), "Radiation" (19 trials) and "Procedure" (16 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (15 trials), "Quality-of-Life Assessment" (14 trials), "Fludarabine" (13 trials), "Cisplatin" (12 trials) and "Questionnaire Administration" (12 trials). Other intervention names were less common.

Clinical Trials Genders at Banner MD Anderson Cancer Center


The vast majority of trials in "Banner MD Anderson Cancer Center" are 165 trials for "All" genders, 8 trials for "Female" genders and 6 trials for "Male" genders.

Clinical Trials Status at Banner MD Anderson Cancer Center


Currently, there are NaN active trials in "Banner MD Anderson Cancer Center". undefined are not yet recruiting, 51 are recruiting, 53 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 41 completed trials in Banner MD Anderson Cancer Center, 2 suspended trials, and 20 terminated clinical trials to date.
Out of the total trials that were conducted in Banner MD Anderson Cancer Center, 50 "Phase 1" clinical trials were conducted, 87 "Phase 2" clinical trials and 59 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 87Phase 2: 87Phase 3: 59Phase 3: 59Phase 1: 50Phase 1: 50Not Applicable: 4Not Applicable: 4Early Phase 1: 1Early Phase 1: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 53Active, not recruiting: 53Recruiting: 51Recruiting: 51Completed: 41Completed: 41Terminated: 20Terminated: 20Unknown status: 4Unknown status: 4Withdrawn: 3Withdrawn: 3Available: 2Available: 2No longer available: 2No longer available: 2Suspended: 2Suspended: 2Enrolling by invitation: 1Enrolling by invitation: 1